The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Pharmaceutical nanotechnology: from the bench to the market
Open accessAbstract
Background: Nanotechnology is considered a new and rapidly emerging area in the pharmaceutical and medicinal field. Nanoparticles, as drug delivery systems, impart several advantages concerning improved efficacy as well as reduced adverse drug reactions. Main body: Different types of nanosystems have been fabricated including carbon nanotubes, paramagnetic nanoparticles, dendrimers, nanoemulsions, etc. Physicochemical properties of the starting materials and the selected method of preparation play a significant aspect in determining the shape and characteristics of the developed nanoparticles. Dispersion of preformed polymers, coacervation, polymerization, nano-spray drying and supercritical fluid technology are among the most extensively used techniques for the preparation of nanocarriers. Particle size, surface charge, surface hydrophobicity and drug release are the main factors affecting nanoparticles physical stability and biological performance of the incorporated drug. In clinical practice, many nanodrugs have been used for both diagnostic and therapeutic applications and are being investigated for various indications in clinical trials. Nanoparticles are used for the cure of kidney diseases, tuberculosis, skin conditions, Alzheimer’s disease, different types of cancer as well as preparation of COVID-19 vaccines. Conclusion: In this review, we will confer the advantages, types, methods of preparation, characterization methods and some of the applications of nano-systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Among these, nanotechnology‐based approaches have transformed the field by enabling the engineering of nanoscale carriers capable of entrapping, encapsulating, dissolving, or binding active pharmaceutical ingredients (APIs) within their matrix [26].”
From Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies (2025) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helical microtubules of graphitic carbon
Iijima, S. (1991) · Nature · doi:10.1038/354056a0 · Cited by 43,126
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,417
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,978
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,845
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Preparation and antibacterial activity of chitosan nanoparticles
Qi, L., Xu, Z., Jiang, X., Hu, C., & Zou, X. (2004) · Carbohydrate Research · doi:10.1016/j.carres.2004.09.007 · Cited by 1,808
Immunotargeted Nanoshells for Integrated Cancer Imaging and Therapy
Loo, C. H., Lowery, A. R., Halas, N. J., West, J. L., & Drezek, R. A. (2005) · Nano Letters · doi:10.1021/nl050127s · Cited by 1,792
Polymer-based nanocapsules for drug delivery
Mora‐Huertas, C. E., Fessi, H., & Elaı̈ssari, A. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.018 · Cited by 1,744
Drug delivery systems: An updated review
Tiwari, G., Tiwari, R., Bannerjee, S., Bhati, L., Pandey, S., Pandey, P., & Sriwastawa, B. (2012) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.96920 · Cited by 1,671
The emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,657
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,494
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Parveen, S., Misra, R., & Sahoo, S. K. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.05.016 · Cited by 1,475
Applications of nanoparticle systems in drug delivery technology
Rizvi, S. A. A., & Saleh, A. (2017) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.10.012 · Cited by 1,398
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. D. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,224
Particle design using supercritical fluids: Literature and patent survey
Jung, J., & Perrut, M. (2001) · The Journal of Supercritical Fluids · doi:10.1016/s0896-8446(01)00064-x · Cited by 1,150
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,116
Direct Fabrication and Harvesting of Monodisperse, Shape-Specific Nanobiomaterials
Rolland, J. P., Maynor, B. W., Euliss, L. E., Exner, A. E., Rothrock, G. D., & DeSimone, J. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051977c · Cited by 849
Nano-niosomes as nanoscale drug delivery systems: An illustrated review
Moghassemi, S., & Hadjizadeh, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.015 · Cited by 800
The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis
Gelperina, S. E., Kisich, K. O., Iseman, M. D., & Heifets, L. B. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-613pp · Cited by 744
Chitosan nanoparticles preparation and applications
Divya, K., & Jisha, M. S. (2017) · Environmental Chemistry Letters · doi:10.1007/s10311-017-0670-y · Cited by 739
Strategies for controlled delivery of growth factors and cells for bone regeneration
Vo, T. N., Kasper, F. K., & Mikos, A. G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.016 · Cited by 681
COVID-19 vaccine development and a potential nanomaterial path forward
Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., Wirth, D. M., Chen, A., Sack, M., Pokorski, J. K., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0737-y · Cited by 660
Niosome: A future of targeted drug delivery systems
Kuotsu, K., Karim, K. M., Mandal, A. S., Biswas, N., Guha, A., Chatterjee, S., & Behera, M. (2010) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/0110-5558.76435 · Cited by 627
Nanotechnology in Therapeutics: A Focus on Nanoparticles as A Drug Delivery System
Bamrungsap, S., Zhao, Z., Chen, T., Wang, L., Li, C., Fu, T., & Tan, W. (2012) · Nanomedicine · doi:10.2217/nnm.12.87 · Cited by 624
Safra, T., Muggia, F. M., Jeffers, S., Tsao-Wei, D. D., Groshen, S. G., Lyass, O., Henderson, R., Berry, G. J., & Gabizón, A. (2000) · Annals of Oncology · doi:10.1023/a:1008365716693 · Cited by 618
Lipid nanoparticles for improved topical application of drugs for skin diseases☆
SCHAFERKORTING, M., MEHNERT, W., & KORTING, H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.006 · Cited by 614
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 597
Nanoparticles and nanofibers for topical drug delivery
Goyal, R., Macri, L. K., Kaplan, H. M., & Kohn, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.049 · Cited by 591
Nanomaterials and supercritical fluids
Reverchon, E., & Adami, R. (2005) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2005.08.003 · Cited by 588
Targeted polymeric micelles for delivery of poorly soluble drugs
Torchilin, V. P. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4153-5 · Cited by 549
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties
Jenning, V., Schäfer‐Korting, M., & Gohla, S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00223-0 · Cited by 548
Mucoadhesive drug delivery system: An overview
Boddupalli, B. M., Mohammed, Z. K., Nath, R., & Banji, D. (2010) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/0110-5558.76436 · Cited by 542
Bhatia, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-41129-3_2 · Cited by 532
Microparticles and nanoparticles for drug delivery
Kohane, D. S. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21301 · Cited by 517
Preparation and characterization of cationic PLGA nanospheres as DNA carriers
Kumar, M. N. V. R., Bakowsky, U., & Lehr, C. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.08.069 · Cited by 499
Verreck, G., Chun, I., Rosenblatt, J., Peeters, J., Dijck, A. V., Mensch, J., Noppe, M., & Brewster, M. E. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00342-0 · Cited by 479
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 475
Emerging implications of nanotechnology on cancer diagnostics and therapeutics
Cuenca, A. G., Jiang, H., Hochwald, S. N., Delano, M. J., Cance, W. G., & Grobmyer, S. R. (2006) · Cancer · doi:10.1002/cncr.22035 · Cited by 473
Klibanov, A. L. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000199292.88189.0f · Cited by 424
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423
Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease
Roney, C. A., Kulkarni, P. V., Arora, V., Antich, P. P., Bonte, F. J., Wu, A., Mallikarjuana, N. N., Manohar, S. K., Liang, H., Kulkarni, A. R., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.024 · Cited by 411
Quantum dots in biology and medicine
Bailey, R. E., Smith, A. M., & Nie, S. (2004) · Physica E Low-dimensional Systems and Nanostructures · doi:10.1016/j.physe.2004.07.013 · Cited by 397
Nano spray drying for encapsulation of pharmaceuticals
Arpagaus, C., Collenberg, A., Rütti, D. P., Assadpour, E., & Jafari, S. M. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.05.037 · Cited by 391
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Cavalli, R., Gasco, M. R., Chetoni, P., Burgalassi, S., & Saettone, M. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00080-7 · Cited by 389
Friedman, A., Phan, J., Schairer, D. O., Champer, J., Qin, M., Pirouz, A., Blecher, K., Oren, A., Liu, P. T., Modlin, R. L., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.399 · Cited by 357
The Liposomal Formulation of Doxorubicin
Abraham, S. A., Waterhouse, D. N., Mayer, L. D., Cullis, P. R., Madden, T. D., & Bally, M. B. (2005) · Methods in Enzymology · doi:10.1016/s0076-6879(05)91004-5 · Cited by 355
The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems
Kayser, O., Lemke, A., & Hernández-Trejo, N. (2005) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201053167158 · Cited by 350
Applications of nanotechnology to biotechnology
West, J. L., & Halas, N. J. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00082-3 · Cited by 343
Sundar, S., Kundu, J., & Kundu, S. C. (2010) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/11/1/014104 · Cited by 329
Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy
Gao, Z., Kennedy, A., Christensen, D. A., & Rapoport, N. Y. (2007) · Ultrasonics · doi:10.1016/j.ultras.2007.11.002 · Cited by 316
A review of imaging techniques for systems biology
Kherlopian, A. R., Song, T., Duan, Q., Neimark, M. A., Po, M. J., Gohagan, J. K., & Laine, A. F. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-74 · Cited by 310
Laverman, P., Carstens, M. G., Boerman, O. C., Dams, E. T. M., Oyen, W. J. G., van Rooijen, N., Corstens, F. H. M., & Storm, G. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29419-2 · Cited by 298
Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method
Kwon, H.-Y., Lee, J.-Y., Choi, S.-W., Jang, Y., & Kim, J.-H. (2001) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(00)00825-6 · Cited by 286
Nazzal, S., Smalyukh, I. I., Lavrentovich, O. D., & Khan, M. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00003-0 · Cited by 273
Pros and Cons of the Liposome Platform in Cancer Drug Targeting
Gabizón, A., Shmeeda, H., & Zalipsky, S. (2006) · Journal of Liposome Research · doi:10.1080/08982100600848769 · Cited by 272
Amoabediny, G., Haghiralsadat, F., Naderinezhad, S., Helder, M. N., Kharanaghi, E. A., Arough, J. M., & Zandieh‐Doulabi, B. (2017) · International Journal of Polymeric Materials · doi:10.1080/00914037.2017.1332623 · Cited by 256
Polymer-Caged Lipsomes: A pH-Responsive Delivery System with High Stability
Lee, S., Chen, H., Dettmer, C. M., O’Halloran, T. V., & Nguyen, S. T. (2007) · Journal of the American Chemical Society · doi:10.1021/ja070748i · Cited by 245
Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments
Karlsson, J. E., Vaughan, H. J., & Green, J. J. (2018) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-060817-084055 · Cited by 244
Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
Wilson, D. R., Sen, R., Sunshine, J. C., Pardoll, D. M., Green, J. J., & Kim, Y. J. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.10.013 · Cited by 225
PEG-Modified Carbon Nanotubes in Biomedicine: Current Status and Challenges Ahead
Bottini, M., Rosato, N., & Bottini, N. (2011) · Biomacromolecules · doi:10.1021/bm201020h · Cited by 220
Pandey, R., Zahoor, A., Sharma, S., & Khuller, G. K. (2003) · Tuberculosis · doi:10.1016/j.tube.2003.07.001 · Cited by 220
Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219
Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine
Singh, K. K., & Vingkar, S. K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.035 · Cited by 215
Biodegradable dendrimers for drug delivery
Huang, D., & Wu, D. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.03.002 · Cited by 203
Near-Infrared Fluorescent Materials for Sensing of Biological Targets
Amiot, C. L., Xu, S., Liang, S., Pan, L., & Zhao, J. X. (2008) · Sensors · doi:10.3390/s8053082 · Cited by 196
Nanoparticles as new tools for inhibition of cancer angiogenesis
Goradel, N. H., Ghiyamihoor, F., Jahangiri, S., Negahdari, B., Sahebkar, A., Masoudifar, A., & Mirzaei, H. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26029 · Cited by 190
Recent advances in nanoparticle-mediated drug delivery
Kumar, B. D., Jalodia, K., Kumar, P., & Gautam, H. K. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.07.019 · Cited by 189
de Moura, S. C. S. R., Berling, C. L., Germer, S. P. M., Alvim, I. D., & Hubinger, M. D. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.08.095 · Cited by 178
Carbon Nanotubes: Potential Benefits and Risks of Nanotechnology in Nuclear Medicine
Reilly, R. M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.041723 · Cited by 172
Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19
Vahedifard, F., & Chakravarthy, K. V. (2021) · Emergent Materials · doi:10.1007/s42247-021-00168-8 · Cited by 129
Jaiswal, J. K., Gupta, S. K., & Kreuter, J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.017 · Cited by 126
Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study
Ubrich, N., Bouillot, P., Pellerin, C., Hoffman, M., & Maincent, P. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.023 · Cited by 125
Cai, Z., Wang, Y., Zhu, L., & Liu, Z. (2010) · Current Drug Metabolism · doi:10.2174/138920010791110836 · Cited by 120
Boudad, H., Legrand, P., Bas, G. L., Chéron, M., Duchêne, D., & Ponchel, G. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00622-6 · Cited by 120
Milane, L. S., & Amiji, M. M. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00911-y · Cited by 119
Nanocapsules formation by nano spray drying
Arpagaus, C., John, P., Collenberg, A., & Rütti, D. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809436-5.00010-0 · Cited by 112
Clinical Potential of Quantum Dots
Iga, A. M., Robertson, J. H. P., Winslet, M. C., & Seifalian, A. M. (2007) · BioMed Research International · doi:10.1155/2007/76087 · Cited by 109
Gharehbeglou, P., Jafari, S. M., Rad, A. H., Hamishekar, H., & Mirzaei, H. O. (2018) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2018.10.020 · Cited by 101
Application of Nanotechnology in the COVID-19 Pandemic
Yang, D. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s296383 · Cited by 99
Jeon, H. S., Seo, J. E., Kim, M. S., Kang, M. H., Oh, D. H., Jeon, S. O., Jeong, S. H., Choi, Y. W., & Lee, S. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.023 · Cited by 94
Polymeric Nanoparticles from Rapid Expansion of Supercritical Fluid Solution
Sun, Y., Meziani, M. J., Pathak, P., & Qu, L. (2004) · Chemistry - A European Journal · doi:10.1002/chem.200400422 · Cited by 85
Pant, A., & Negi, J. S. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.11.020 · Cited by 77
PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers
Li, Y., Pei, Y., Zhou, Z.-H., Zhang, X., Gu, Z.-H., Ding, J., Zhou, J.-J., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00235-8 · Cited by 76
Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease
Belete, T. M. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s288877 · Cited by 74
Noor, R. (2021) · Current Clinical Microbiology Reports · doi:10.1007/s40588-021-00162-y · Cited by 72
Chen, D., Han, S., Zhu, Y., Hu, F., Wei, Y., & Wang, G. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s166445 · Cited by 72
Sundar, S., & Prajapati, V. K. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800784630 · Cited by 61
Engineering biodegradable nanoparticles for drug and gene delivery.
Zhang, J., & Saltzman, W. M. (2013) · PubMed · Cited by 60
Abel, S. B., Yslas, E. I., Rivarola, C. R., & Barbero, C. A. (2018) · Nanotechnology · doi:10.1088/1361-6528/aaa99a · Cited by 59
Applications of Nanoparticles in the Detection and Treatment of Kidney Diseases
Brede, C., & Labhasetwar, V. D. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.07.006 · Cited by 55
Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles
López‐López, M., Fernández-Delgado, A., Moyá, M. L., Blanco-Arévalo, D., Sánchez, C. C., de la Haba, R. R., Ventosa, A., Bernal, E., & López‐Cornejo, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020057 · Cited by 50
Malik, T., Chauhan, G., Rath, G., Kesarkar, R. N., Chowdhary, A. S., & Goyal, A. K. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1414054 · Cited by 49
Fabrication of superhydrophobic cotton fabrics using crosslinking polymerization method
Jiang, B., Chen, Z. X., Sun, Y., Yang, H., Zhang, H., Dou, H., & Zhang, L. (2018) · Applied Surface Science · doi:10.1016/j.apsusc.2018.01.285 · Cited by 46
Recent Advances in Liposomal Drug Delivery: A Review
Nekkanti, V., & Kalepu, S. (2015) · Pharmaceutical Nanotechnology · doi:10.2174/2211738503666150709173905 · Cited by 43
Lactoferrin-modified Betulinic Acid-loaded PLGA nanoparticles are strong anti-leishmanials
Halder, A., Shukla, D., Das, S., Roy, P., Mukherjee, A., & Saha, B. (2018) · Cytokine · doi:10.1016/j.cyto.2018.05.010 · Cited by 39
Non-isocyanate polyurethane nanoparticles prepared by nanoprecipitation
Quérette, T., Fleury, É., & Sintès‐Zydowicz, N. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.03.006 · Cited by 34
Loya-Castro, M. F., Sánchez-Mejía, M., Sánchez-Ramírez, D. R., Domínguez-Ríos, R., Escareño, N., Oceguera-Basurto, P. E., Ochoa, E. B. F., Ramos, A. Q., Toro‐Arreola, A. D., Topete, A., et al. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.02.013 · Cited by 31
Mondal, J., Patra, M., Panigrahi, A. K., & Khuda‐Bukhsh, A. R. (2018) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2017.11.002 · Cited by 22
Improvement of N-Acetylcysteine Loaded in PLGA Nanoparticles by Nanoprecipitation Method
Lancheros, R. J., Guerrero, C., & Godoy‐Silva, R. D. (2018) · Journal of Nanotechnology · doi:10.1155/2018/3620373 · Cited by 21
Preparation of Nanoparticles by Solvent Displacement Using a Novel Recirculation System
Piñón‐Segundo, E., Ganem‐Rondero, A., Bermúdez, J. R. G., Escobar‐Chávez, J. J., López-Cervantes, M., & Quintanar‐Guerrero, D. (2006) · Pharmaceutical Development and Technology · doi:10.1080/10837450600940824 · Cited by 21
Deng, Y., Yang, F., Zhao, X., Wang, L., Wu, W., Zu, C., & Wu, M. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.12.024 · Cited by 19
Hong, J. S., Srivastava, D., & Lee, I. (2018) · Journal of Applied Polymer Science · doi:10.1002/app.46199 · Cited by 19
Dendronization of gold nanoparticles decreases their effect on human alpha-1-microglobulin
Pędziwiatr‐Werbicka, E., Serchenya, T. S., Shcharbin, D., Terehova, M., Prokhira, E., Dzmitruk, V., Shyrochyna, I., Sviridov, O. V., González, C. E. P., Gómez, R., et al. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.11.004 · Cited by 13
Shah, H. S., Khalid, F., Bashir, S., Asad, M. H. H. B., Khan, K.-U.-R., Usman, F., & Javed, I. (2019) · Journal of Nanoparticle Research · doi:10.1007/s11051-019-4464-y · Cited by 10
Hawkins, M., Saha, S., Ravindran, E., & Rathnayake, H. P. (2018) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.29295 · Cited by 9
Alexandrova, I., & Iordanov, G. (1997) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19970103)63:1 · Cited by 5
Research works printed but not linked: 6
- Mohanraj V, Chen Y (2006) Nanoparticles-a review. Trop J Pharm Res 5(1):561–573
- Saad ZH, Jahan R, Bagul U (2012) Nanopharmaceuticals: a new perspective of drug delivery system. Asian J Biomed Pharm Sci 2(14):11–20
- Kalele SW, Gosavi S, Urbn J, Kulkarni S (2006) Nanoshell particles: synthesis, properties and applications. Curr Sci 91(8):1038–1052
- Kompella U, Bandi N, Ayalasomayajula S (2001) Poly (lactic acid) nanoparticles for sustained release of budesonide. Drug Deliv Technol 1:1–7
- Shinde NC, Keskar NJ, Argade PD (2012) Nanoparticles: advances in drug delivery systems. Res J Pharm Biol Chem Sci 3:922–929
- Jahangiri A, Barghi L (2018) Polymeric nanoparticles: review of synthesismethods and applications in drug delivery. J Adv Chem Pharm Mater 1(2):38–47
Cited by
Sorted by citations
Nanotechnology: A Revolution in Modern Industry
Malik, S., Muhammad, K., & Waheed, Y. (2023) · Molecules · doi:10.3390/molecules28020661 · Cited by 1,112
Emerging Applications of Nanotechnology in Healthcare and Medicine
Malik, S., Muhammad, K., & Waheed, Y. (2023) · Molecules · doi:10.3390/molecules28186624 · Cited by 610
Nanomedicine-based commercial formulations: current developments and future prospects
Thapa, R. K., & Kim, J. O. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00607-6 · Cited by 251
Pires, P. C., Mascarenhas‐Melo, F., Pedrosa, K., Lopes, D., Lopes, J., Macário‐Soares, A., Peixoto, D., Giram, P. S., Veiga, F., & Paiva‐Santos, A. C. (2023) · European Polymer Journal · doi:10.1016/j.eurpolymj.2023.111868 · Cited by 225
Liga, S., Paul, C., Moacă, E.-A., & Péter, F. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020223 · Cited by 162
Metadata
- Authors
- Mazayen, Z. M., Ghoneim, A. M., Elbatanony, R. S., Basalious, E. B., & Bendas, E. R.
- Affiliations
- Future University in Egypt (EG)
- Cairo University (EG)
- Corresponding author
- Ghoneim, Amira M.
- Venue
- Future Journal of Pharmaceutical Sciences
- Published
- 2022-01-15
- Volume
- 8
- Issue
- 1
- Pages
- 12-12
- ISSN
- 2314-7245 (ISSN-L)
- 2314-7253
- PMC
- PMC8760885
- OpenAlex
- W4205766471
- Cited by
- 208
- References
- 109
- Citations by year
- 2026: 33 · 2025: 58 · 2024: 57 · 2023: 51 · 2022: 9
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Future Journal of Pharmaceutical Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Pharmacology and Nanomedicine Research
- Keywords
- pharmaceutical nanotechnology, nanoparticles, drug delivery systems, nanocarriers, carbon nanotubes, paramagnetic nanoparticles, dendrimers, nanoemulsions, coacervation, nano spray drying, supercritical fluid technology, particle size, surface charge, drug release, physical stability, clinical trials, nanotherapeutics, COVID-19 vaccines, cancer therapy, Alzheimer's disease, tuberculosis, kidney disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review